RU2012117746A - Композиции, содержащие противовоспалительную смесь - Google Patents
Композиции, содержащие противовоспалительную смесь Download PDFInfo
- Publication number
- RU2012117746A RU2012117746A RU2012117746/15A RU2012117746A RU2012117746A RU 2012117746 A RU2012117746 A RU 2012117746A RU 2012117746/15 A RU2012117746/15 A RU 2012117746/15A RU 2012117746 A RU2012117746 A RU 2012117746A RU 2012117746 A RU2012117746 A RU 2012117746A
- Authority
- RU
- Russia
- Prior art keywords
- extract
- inhibitor
- composition
- group
- inflammatory compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
1. Композиция, содержащая:ингибитор NF-kB; ипротивовоспалительное соединение, которое не является ингибитором NF-kB и имеет концентрацию IC50 приблизительно 70 мкг/мл или менее.2. Композиция по п.1, в которой противовоспалительное соединение имеет концентрацию IC50 приблизительно 50 мкг/мл или менее.3. Композиция по п.1, в которой противовоспалительное соединение имеет концентрацию IC50 приблизительно 40 мкг/мл или менее.4. Композиция по п.1, в которой противовоспалительное соединение представляет собой экстракт, выбранный из группы, состоящей из экстракта луба амурского бархата (), пиретрума девичьего (), гинкго (), скумпии (), дерезы обыкновенной (), экстракта чертополоха морского (), масла амаранта (), гранатового дерева (), травы мате (экстракта листьев), экстракта цветов лилии белой (), экстракта листьев оливы (), флоретина (экстракта яблока), а также их комбинаций.5. Композиция по п.1, в которой противовоспалительное соединение представляет собой экстракт, выбранный из группы, состоящей из пиретрума девичьего (), дерезы обыкновенной (), экстракта чертополоха морского (), масла амаранта (), гранатового дерева (), травы мате (экстракта листьев), экстракта цветов лилии белой (), экстракта листьев оливы (), флоретина (экстракта яблока), а также их комбинаций.6. Композиция по п.1, в которой ингибитор NF-kB выбран из группы, состоящей из замещенных резорцинолов, (E)-3-(4-метилфенилсульфонил)-2-пропеннитрила, тетрагидрокуркуминоидов, экстрактов древесины павловнии войлочной, а также их комбинаций.7. Композиция по п.1, в которой ингибитор NF-kB выбран из группы, состоящей из замещенных резорцинолов, тетрагидрокуркуминоидов и их комбинаций.8. Композиция по п.4, в ко�
Claims (10)
1. Композиция, содержащая:
ингибитор NF-kB; и
противовоспалительное соединение, которое не является ингибитором NF-kB и имеет концентрацию IC50 приблизительно 70 мкг/мл или менее.
2. Композиция по п.1, в которой противовоспалительное соединение имеет концентрацию IC50 приблизительно 50 мкг/мл или менее.
3. Композиция по п.1, в которой противовоспалительное соединение имеет концентрацию IC50 приблизительно 40 мкг/мл или менее.
4. Композиция по п.1, в которой противовоспалительное соединение представляет собой экстракт, выбранный из группы, состоящей из экстракта луба амурского бархата (Phellodendron amurense), пиретрума девичьего (Tanacetum parthenium), гинкго (Ginkgo Biloba), скумпии (Cotinus coggygria), дерезы обыкновенной (Lycium barbarum), экстракта чертополоха морского (Silybum marianum), масла амаранта (Amaranthus cruentus), гранатового дерева (Punica granatum), травы мате (экстракта листьев Ilex paraguariensis), экстракта цветов лилии белой (Lilium Candidum), экстракта листьев оливы (Olea europaea), флоретина (экстракта яблока), а также их комбинаций.
5. Композиция по п.1, в которой противовоспалительное соединение представляет собой экстракт, выбранный из группы, состоящей из пиретрума девичьего (Tanacetum parthenium), дерезы обыкновенной (Lycium barbarum), экстракта чертополоха морского (Silybum marianum), масла амаранта (Amaranthus cruentus), гранатового дерева (Punica granatum), травы мате (экстракта листьев Ilex paraguariensis), экстракта цветов лилии белой (Lilium Candidum), экстракта листьев оливы (Olea europaea), флоретина (экстракта яблока), а также их комбинаций.
6. Композиция по п.1, в которой ингибитор NF-kB выбран из группы, состоящей из замещенных резорцинолов, (E)-3-(4-метилфенилсульфонил)-2-пропеннитрила, тетрагидрокуркуминоидов, экстрактов древесины павловнии войлочной, а также их комбинаций.
7. Композиция по п.1, в которой ингибитор NF-kB выбран из группы, состоящей из замещенных резорцинолов, тетрагидрокуркуминоидов и их комбинаций.
8. Композиция по п.4, в которой ингибитор NF-kB выбран из группы, состоящей из замещенных резорцинолов, тетрагидрокуркуминоидов и их комбинаций.
9. Композиция по п.5, в которой ингибитор NF-kB выбран из группы, состоящей из замещенных резорцинолов, тетрагидрокуркуминоидов и их комбинаций.
10. Композиция по п.1, в которой ингибитор NF-kB и противовоспалительное соединение присутствуют в весовом соотношении от приблизительно 1:10 до приблизительно 10:1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24799209P | 2009-10-02 | 2009-10-02 | |
US61/247,992 | 2009-10-02 | ||
PCT/US2010/051080 WO2011041648A1 (en) | 2009-10-02 | 2010-10-01 | Compositions comprising an anti-inflammatory blend |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012117746A true RU2012117746A (ru) | 2013-11-10 |
RU2554766C2 RU2554766C2 (ru) | 2015-06-27 |
Family
ID=43127098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012117746/15A RU2554766C2 (ru) | 2009-10-02 | 2010-10-01 | Композиции, содержащие противовоспалительную смесь |
Country Status (11)
Country | Link |
---|---|
US (1) | US8318217B2 (ru) |
EP (1) | EP2482809B1 (ru) |
KR (1) | KR101750296B1 (ru) |
CN (1) | CN102573820B (ru) |
BR (1) | BR112012007512A2 (ru) |
CA (1) | CA2774026C (ru) |
ES (1) | ES2674569T3 (ru) |
HK (1) | HK1171954A1 (ru) |
IN (1) | IN2012DN02441A (ru) |
RU (1) | RU2554766C2 (ru) |
WO (1) | WO2011041648A1 (ru) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110081430A1 (en) * | 2009-10-02 | 2011-04-07 | Simarna Kaur | COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER |
US8906432B2 (en) * | 2009-10-02 | 2014-12-09 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter |
US8084504B2 (en) | 2009-10-02 | 2011-12-27 | Johnson & Johnson Consumer Companies, Inc. | High-clarity aqueous concentrates of 4-hexylresorcinol |
US9173913B2 (en) | 2010-08-19 | 2015-11-03 | Johnson & Johnson Consumer Inc. | Compositions comprising Paulownia tomentosa wood extracts and uses thereof |
WO2012024395A2 (en) * | 2010-08-19 | 2012-02-23 | Johnson & Johnson Consumer Companies Inc. | Compositions comprising paulwnin and/or paulownia extracts and uses thereof |
US9168207B2 (en) | 2010-08-19 | 2015-10-27 | Johnson & Johnson Consumer Inc. | Compositions comprising Paulownia tomentosa wood extracts and uses thereof |
US9161958B2 (en) | 2010-08-19 | 2015-10-20 | Johnson & Johnson Consumer Inc. | Methods of treating cellulite |
US9168279B2 (en) | 2010-08-19 | 2015-10-27 | Johnson & Johnson Consumer Inc. | Compositions comprising paulownin and/or Paulownia extracts and uses thereof |
US9387349B2 (en) | 2010-08-19 | 2016-07-12 | Johnson & Johnson Consumer Inc. | Compositions comprising Paulownia tomentosa wood extracts and uses thereof |
US9168219B2 (en) | 2010-08-19 | 2015-10-27 | Johnson & Johnson Consumer Inc. | Compositions comprising Paulownia tomentosa wood extracts and uses thereof |
US9962326B2 (en) | 2010-08-19 | 2018-05-08 | Johnson & Johnson Consumer Inc. | Compositions comprising paulownia tomentosa wood extracts and uses thereof |
US8846013B2 (en) | 2012-06-29 | 2014-09-30 | Johnson & Johnson Consumer Companies, Inc. | Topical application of 1-hydroxyl-3,5-BIS(4′hydroxy styryl)benzene |
CN104411288B (zh) * | 2012-06-29 | 2017-10-17 | 强生消费者公司 | 1‑羟基3,5‑双(4’羟基苯乙烯基)苯的局部施用 |
US8758731B2 (en) | 2012-06-29 | 2014-06-24 | Johnson & Johnson Consumer Companies, Inc. | Skin lightening by topical application of 1-hydroxyl 3,5-bis(4′hydroxyl styryl)benzene |
US20140086859A1 (en) | 2012-09-24 | 2014-03-27 | Johnson & Johnson Consumer Companies, Inc. | Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester |
US10130576B2 (en) | 2012-11-13 | 2018-11-20 | Johnson & Johnson Consumer Inc. | Oral care compositions |
CN104768525B (zh) | 2013-05-01 | 2017-09-26 | 宝洁公司 | 化妆品组合物和用于抑制黑素合成的方法 |
US20150272837A1 (en) | 2014-03-27 | 2015-10-01 | Johnson & Johnson Consumer Companies, Inc. | Topical Compositions Comprising A Resorcinol and Powders |
CA2958428C (en) | 2014-09-12 | 2020-08-18 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
CN106177403A (zh) * | 2016-09-19 | 2016-12-07 | 四川易创生物科技有限公司 | 一种可有效治疗肝肾阴虚的汤剂药物及其制备方法 |
CN107184482A (zh) * | 2017-06-26 | 2017-09-22 | 上海家化联合股份有限公司 | 马黛茶提取物及其在皮肤外用剂中的应用 |
US20200405603A1 (en) | 2019-06-25 | 2020-12-31 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating skin conditions using infrared light and resorcinols |
US10537534B1 (en) | 2019-06-25 | 2020-01-21 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating skin conditions using visible light and resorcinols |
WO2021018936A1 (en) * | 2019-07-29 | 2021-02-04 | Echo Pharmaceuticals B.V. | Treatment of inflammatory skin conditions |
KR102346078B1 (ko) * | 2020-01-15 | 2022-01-03 | 경희대학교 산학협력단 | 엉겅퀴 발효물 제조방법 및 이의 방법으로 제조된 항염증용 조성물 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1649670A (en) * | 1923-11-08 | 1927-11-15 | Sharp & Dohme Inc | Hexyl resorcinol |
US3193507A (en) * | 1961-08-30 | 1965-07-06 | Henry R Jacobs | Method of cleaning glass |
US4093667A (en) * | 1977-03-14 | 1978-06-06 | Continental Oil Company | Preparation of 4-n-hexylresorcinol |
US4337370A (en) | 1979-11-08 | 1982-06-29 | Sumitomo Chemical Company, Limited | Process for the preparation of resorcinol derivatives |
JPH0651619B2 (ja) * | 1988-05-09 | 1994-07-06 | 株式会社クラレ | 美白剤 |
US5705145A (en) * | 1996-08-21 | 1998-01-06 | E-L Management Corp. | Skin tanning compositions and method |
JPH11100324A (ja) * | 1997-09-29 | 1999-04-13 | Lion Corp | ニキビ治療用組成物 |
JP4004182B2 (ja) | 1999-05-24 | 2007-11-07 | ポーラ化成工業株式会社 | 乳化組成物 |
JP4615671B2 (ja) | 2000-04-20 | 2011-01-19 | ポーラ化成工業株式会社 | 炎症存在下使用用のしわ形成又は皮膚の弾力喪失の防止剤 |
DE10118889A1 (de) | 2001-04-18 | 2002-10-24 | Goldwell Gmbh | Haarfärbemittel |
DE10118894A1 (de) | 2001-04-18 | 2002-10-24 | Goldwell Gmbh | Verfahren zum oxidativen Färben von menschlichen Haaren |
US6863897B2 (en) * | 2002-03-22 | 2005-03-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Stabilization of resorcinol derivatives in cosmetic compositions |
US6869598B2 (en) * | 2002-03-22 | 2005-03-22 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Stabilization of sunscreens in cosmetic compositions |
AU2003220567A1 (en) | 2002-03-28 | 2003-10-13 | Johnson And Johnson Consumer Companies, Inc. | Compostions for darkening the skin |
US6852310B2 (en) * | 2002-08-23 | 2005-02-08 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Skin lightening agents, compositions and methods |
JP3962666B2 (ja) | 2002-09-13 | 2007-08-22 | 株式会社クラレ | 皮膚外用剤 |
US20040109832A1 (en) * | 2002-12-09 | 2004-06-10 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Di-substituted resorcinols as skin lightening agents |
US6875425B2 (en) | 2002-12-12 | 2005-04-05 | Unilever Home & Personal Care Usa | Skin lightening agents, compositions and methods |
GB2398496A (en) * | 2003-02-20 | 2004-08-25 | Reckitt Benckiser Healthcare | Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles |
EP1613295A1 (en) * | 2003-04-15 | 2006-01-11 | Unilever N.V. | Use of alkyl resorcinols in the treatment of acne |
GB2438999B (en) | 2003-06-13 | 2008-01-16 | Engelhard Lyon | Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibres |
US7320797B2 (en) * | 2003-08-29 | 2008-01-22 | Bioderm Research | Antiaging cosmetic delivery systems |
GB2415135A (en) * | 2004-06-15 | 2005-12-21 | Reckitt Benckiser | Improvements in and relating to depilatory compositions |
US20060019002A1 (en) * | 2004-07-26 | 2006-01-26 | Harvest Food Co., Ltd. | Method for processing, storing and transporting garlic |
US20060120975A1 (en) * | 2004-12-02 | 2006-06-08 | Colgate-Palmolive Company | Oral care composition comprising a phenolic compound and antioxidant vitamins and vitamin derivatives |
US8278359B2 (en) * | 2005-02-25 | 2012-10-02 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin |
US20060210497A1 (en) * | 2005-03-18 | 2006-09-21 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Novel resorcinol derivatives |
US20060210498A1 (en) * | 2005-03-18 | 2006-09-21 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Novel resorcinol derivatives for skin |
EP1865929A2 (en) * | 2005-03-28 | 2007-12-19 | Bioresponse, L.L.C. | Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
BRPI0610180A2 (pt) * | 2005-05-24 | 2012-09-25 | Wellgen Inc | métodos para prevenir, para tratar, e para tratar ou controlar uma condição associada à inflamação |
JP2006327965A (ja) | 2005-05-25 | 2006-12-07 | Pola Chem Ind Inc | 皮膚外用剤とその適用 |
BRPI0707660A2 (pt) | 2006-02-14 | 2011-05-10 | Pola Chem Ind Inc | cosmÉtico para clareamento da pele |
ES2625848T3 (es) | 2006-02-21 | 2017-07-20 | Isp Investment Inc | Ingredientes activos de matricaria (tanacetum parthenium) libres de partenolida y proceso para su producción |
JP2007254412A (ja) | 2006-03-24 | 2007-10-04 | Kuraray Co Ltd | シワの予防及び/又は改善のための皮膚外用剤 |
US20080026974A1 (en) * | 2006-07-27 | 2008-01-31 | Barnhart Ronald A | Antimicrobial hand wash |
US20100124539A1 (en) * | 2006-10-16 | 2010-05-20 | Hanson Medical, Inc. | Cosmetic preparations |
JP5015620B2 (ja) | 2007-01-30 | 2012-08-29 | 株式会社クラレ | 皮膚外用剤 |
US20080241085A1 (en) | 2007-03-29 | 2008-10-02 | Lin Connie B | Compositions for use in darkening the skin |
US20080286217A1 (en) * | 2007-05-14 | 2008-11-20 | Chaudhuri Ratan K | Sunscreen compositions and methods |
ES2622679T3 (es) | 2007-05-14 | 2017-07-07 | Sytheon Ltd. | Composiciones y métodos de protección solar |
US20080305059A1 (en) * | 2007-06-06 | 2008-12-11 | Chaudhuri Ratan K | Skin lightening compositions and methods |
US8409637B2 (en) * | 2007-06-21 | 2013-04-02 | Puramed Bioscience Inc. | Compositions and methods for treating and preventing migrainous headaches and associated symptoms |
JP2009084164A (ja) | 2007-09-27 | 2009-04-23 | Septem Soken:Kk | 老化防止剤 |
US20090087395A1 (en) | 2007-10-01 | 2009-04-02 | Lin Connie B | Compositions for use in darkening the skin |
JP2011512409A (ja) * | 2008-02-20 | 2011-04-21 | イーエルシー マネージメント エルエルシー | 皮膚を美白するための局所組成物及び方法 |
US9676696B2 (en) * | 2009-01-29 | 2017-06-13 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
US20110081305A1 (en) * | 2009-10-02 | 2011-04-07 | Steven Cochran | Compositions comprising a skin-lightening resorcinol and a skin darkening agent |
US8084504B2 (en) * | 2009-10-02 | 2011-12-27 | Johnson & Johnson Consumer Companies, Inc. | High-clarity aqueous concentrates of 4-hexylresorcinol |
US8906432B2 (en) * | 2009-10-02 | 2014-12-09 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter |
US20110081430A1 (en) * | 2009-10-02 | 2011-04-07 | Simarna Kaur | COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER |
-
2010
- 2010-10-01 US US12/896,250 patent/US8318217B2/en not_active Expired - Fee Related
- 2010-10-01 CA CA2774026A patent/CA2774026C/en not_active Expired - Fee Related
- 2010-10-01 BR BR112012007512A patent/BR112012007512A2/pt not_active IP Right Cessation
- 2010-10-01 IN IN2441DEN2012 patent/IN2012DN02441A/en unknown
- 2010-10-01 WO PCT/US2010/051080 patent/WO2011041648A1/en active Application Filing
- 2010-10-01 EP EP10762844.8A patent/EP2482809B1/en active Active
- 2010-10-01 KR KR1020127011431A patent/KR101750296B1/ko active IP Right Grant
- 2010-10-01 RU RU2012117746/15A patent/RU2554766C2/ru not_active IP Right Cessation
- 2010-10-01 CN CN201080045045.0A patent/CN102573820B/zh not_active Expired - Fee Related
- 2010-10-01 ES ES10762844.8T patent/ES2674569T3/es active Active
-
2012
- 2012-12-12 HK HK12112862.6A patent/HK1171954A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2674569T3 (es) | 2018-07-02 |
KR101750296B1 (ko) | 2017-06-23 |
CN102573820A (zh) | 2012-07-11 |
US20110081433A1 (en) | 2011-04-07 |
KR20120083448A (ko) | 2012-07-25 |
CA2774026A1 (en) | 2011-04-07 |
EP2482809B1 (en) | 2018-06-13 |
EP2482809A1 (en) | 2012-08-08 |
BR112012007512A2 (pt) | 2016-11-22 |
US8318217B2 (en) | 2012-11-27 |
CN102573820B (zh) | 2015-11-25 |
WO2011041648A1 (en) | 2011-04-07 |
CA2774026C (en) | 2018-04-24 |
HK1171954A1 (zh) | 2013-04-12 |
IN2012DN02441A (ru) | 2015-08-21 |
RU2554766C2 (ru) | 2015-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2012117746A (ru) | Композиции, содержащие противовоспалительную смесь | |
Aruljothi et al. | Investigation on antibacterial activity of Carica papaya leaf extracts against wound infection-causing bacteria | |
BRPI0508263A (pt) | derivados de 1, 2, 3, 4-tetra-hidro-isoquinolina, composição farmacêutica, e, uso de derivado de 1, 2, 3, 4-tetra-hidro-isoquinolina | |
Sayeed et al. | In vitro antimicrobial activity of methanolic extract of Moringa olieifera lam. fruits | |
BRPI0519280A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto | |
BR112012028279A2 (pt) | "combinações de compostos anti-fúngicos e óleo de melaleuca" | |
Neeraja et al. | Cardioprotective activity of fruits of Sechium edule | |
RU2011129991A (ru) | Композиции, включающие липофильный экстракт zingiber officinale и экстракт cynara scolymus, которые используются для профилактики и лечения гастроэзофагеального рефлюкса и синдрома воспаленной кишки | |
US11554153B2 (en) | Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof | |
CA2541768C (en) | Use of knotwood extracts as antioxidants | |
Sánchez et al. | Antioxidant activity of Rhizophora mangle bark | |
Hossain et al. | Antidiarrhoeal activity, nitric oxide scavenging and total tannin content from the bark of Ceriops decandra (griff.) Ding hou | |
RU2008143151A (ru) | Средство для дезинфекции и санации воздуха | |
EA201000432A1 (ru) | Фунгицидные смеси тритиконазола и дифеноконазола | |
Karim et al. | Free radical scavenging, antidiarrheal and anthelmintic activity of Pistia stratiotesL. extracts and its phytochemical analysis | |
BR112022014040A2 (pt) | Composição de extrato vegetal para o tratamento de doenças cariovasculares e metabólicas | |
RU2007130551A (ru) | Пероральные композиции для предотвращения повреждения уф лучами | |
KR20170053544A (ko) | 겨우살이, 편백나무, 참나무 및 동백나무 혼합추출물을 유효성분으로 함유하는 피부 보습 및 항노화용 화장료 조성물 | |
RU2009143215A (ru) | Состав лекарственный фитосубстанции с антимикробными и противовоспалительными свойствами "дентос" | |
MX349868B (es) | Composiciones de gel. | |
RU2008140247A (ru) | Лечебно-профилактическое средство для наружного и/или внутреннего применения | |
Lacuna et al. | Antimicrobial activity of supercritical fluid extracts of two Philippine medicinal plants, Psidium guajava and Euphorbia hirta: Implications to community health | |
RU2007122530A (ru) | Биологически активная добавка | |
Adesina et al. | Inhibitory effects of the volatile oils of Callistemon citrinus (Curtis) Skeels and Eucalyptus citriodora Hook (Myrtaceae) on the acetylcholine induced contraction of isolated rat ileum. | |
Mohanty et al. | Gastric ulcer healing activity of Tecoma stans Leaf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20201002 |